Sabizabulin on "Short Path to FDA EMA", Will "Serve Critical Roles in the US and Abroad" - Veru (VERU) PT Hiked to $36 at Oppenheimer,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
Go back to Sabizabulin on "Short Path to FDA EMA", Will "Serve Critical Roles in the US and Abroad" - Veru (VERU) PT Hiked to $36 at Oppenheimer,
April 12, 2022 6:36 AM EDT
Veru, Inc. (NASDAQ: VERU) Extends Yesterday's Gain as Analysts Raise Price Target, Up Another 15%
Climbed 180% Yesterday Following Data
...
More